Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Last updated: April 19, 2025
Sponsor: IRCCS San Raffaele
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pelvic Cancer

Vaginal Cancer

Treatment

Image Guided Radiotherapy

Clinical Study ID

NCT06306170
GYN-ART
  • Ages 18-90
  • Female

Study Summary

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • gynecologic cancer patients

  • >18 years old

  • treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)

Exclusion

Exclusion Criteria:

  • other tumors

  • > 90 years old

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Image Guided Radiotherapy
Phase:
Study Start date:
February 15, 2024
Estimated Completion Date:
February 15, 2029

Study Description

The patients with gynecological cancer treated with Advanced Radiotherapy (ART)- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- at the Department of Radiotherapy of "IRCCS San Raffaele Scientific Institute" (IRCCSSRaffaele) from January 2005 to January 2024 will be identified and their clinical and dosimetric data retrieved and analyzed.

The study objectives are the analysis of acute and late toxicity, and clinical outcomes, such as local, regional and distant control,disease free survival, cancer-specific survival, and overall survival. Secondary objective is the identification of prognostic factors for toxicity, disease progression, survival, including radiomic characteristics.

Connect with a study center

  • San Raffaele Scientific Institute

    Milan, MI 20132
    Italy

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.